Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

KLVZ Kristall in summer will put into operation a new blending shop

3/4/24 KLVZ

Rusagro awaits Cyprus' authorization for redomiciliation

3/4/24 RAGR

Rusagro paid almost ₽21 billion for 50% of NMZhK

3/4/24 RAGR

Severstal reported for 2023 by RAS

3/4/24 CHMF

SberMarket has launched catering delivery in St. Petersburg

3/4/24 SBER

Yandex.Market launched its own brand of pet products Lapsville

3/4/24 YNDX

Rusagro reports for 2023

3/4/24 RAGR

Debts of energy sales companies can be paid by consumers

3/4/24 FEES

Gazprom sells assets in the North Sea

3/4/24 GAZP

VTB reported for 2023 by RAS

3/1/24 VTBR